ARR Autopsy

Pricing Page Autopsy: The A/B Test That 2x'd Close Rates


Listen Later

A $280K ARR, three-person B2B SaaS team ran on gut-feel pricing for fourteen months while trial-to-paid conversion sat at 3.1% — less than half the ChartMogul 2026 median of 8.9% — until a first-ever MRR dip in month fifteen forced a systematic approach to pricing experimentation. This is the Wednesday episode for Week 20 of 2026.

  • How a tier restructure moved one feature down one level and lifted page-to-trial conversion by 18%, from 3.1% to 3.7%, on five weeks of thin but sufficient traffic
  • Why flipping the billing toggle default from monthly to annual pushed annual plan mix from 15% to 41% of new sign-ups in five weeks
  • How the tier restructure drove a 37% churn reduction by aligning feature packaging with solo-operator needs and opening meaningful expansion ARR growth in the following six months
  • Why the founder rejected usage-based overages to protect ARR predictability, and how a homegrown billing system collapsed under three concurrent plan versions before a three-week hard-stop fix restored order

Guest: founder and CEO, ARR at time of recording $280K, B2B SaaS. If this episode changes how you think about pricing and growth, share it with one founder who needs it and subscribe on YouTube or your podcast app.

...more
View all episodesView all episodes
Download on the App Store

ARR AutopsyBy ARR Autopsy